75
16
Growth Score 75 in past quarter
0 pts
Heat Score 16 in past quarter
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
908946
Diagnomics operates as a Next Generation Sequencing (NGS)-based genomics company.
- Stefan Gruenwald: President and Co-Founder
- Min Seob Lee: Founder and ChairmanPast Role: Sequenom, Principal Scientist / Senior Group Leader Diagnostic Development
About the Company
Diagnomics operates as a Next Generation Sequencing (NGS)-based genomics company. Diagnomics’ mission is to provide sophisticated solutions for personalized medicine and next generation healthcare. Diagnomics offers high quality innovative R&D and CLIA services to global pharmaceutical, biotech and medical device companies as well as academic
institutions.